FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:738-748 September 5, 2002 Number 10 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

IgA nephropathy is a relatively newly recognized disease, first described by Berger and Hinglais in 1968.¹ It is now generally known to be the most common form of primary glomerulonephritis throughout the world.^2,3,4

Primary IgA nephropathy is an immune-complex–mediated glomerulonephritis defined immunohistologically by the presence of glomerular IgA deposits accompanied by a variety of histopathologic lesions.^5,6 Although primary IgA nephropathy receives the most attention, many other diseases are also associated with glomerular IgA deposits (Table 1). The most common of these is Schönlein–Henoch purpura. This condition may indeed be indistinguishable from primary IgA nephropathy and may represent a . . . [Full Text of this Article]

Demographic Features

Incidence

Causes and Genetic Factors

Pathogenesis

Pathology

Clinical Features

Outcome

Treatment

Angiotensin-Converting–Enzyme Inhibitors

Corticosteroids

n–3 Polyunsaturated Fatty Acids

Other Treatments

Renal Transplantation

Differential Diagnosis

Summary

Source Information

From the Division of Nephrology, Department of Medicine (J.V.D.), and the Department of Laboratory Medicine and Pathology (J.P.G.), Mayo Clinic and Mayo Foundation, Rochester, Minn.

Address reprint requests to Dr. Donadio at the Mayo Clinic, 200 First St. SW, Stabile 7-22, Rochester, MN 55905, or at donadio.james@mayo.edu.

Related Letters:

IgA Nephropathy
Heine G., Sester U., Kohler H., Wardle E. N., Sedlacek M., Donadio J. V., Grande J. P.
Extract | Full Text | PDF  
N Engl J Med 2003; 348:79-81, Jan 2, 2003. Correspondence

This article has been cited by other articles:

• Jacquet, A., Francois, H., Frangie, C., Yahiaoui, Y., Ferlicot, S., Micelli, C., Mariette, X., Durrbach, A. (2009). IgA nephropathy associated with ankylosing spondylitis is not controlled by infliximab therapy. Nephrol Dial Transplant 24: 3540-3542 [Abstract] [Full Text]  
• Vuong, M. T., Lundberg, S., Gunnarsson, I., Wramner, L., Seddighzadeh, M., Hahn-Zoric, M., Fernstrom, A., Hanson, L. A, Do, L. T., Jacobson, S. H., Padyukov, L. (2009). Genetic variation in the transforming growth factor-{beta}1 gene is associated with susceptibility to IgA nephropathy. Nephrol Dial Transplant 24: 3061-3067 [Abstract] [Full Text]  
• Xiao, J., Leung, J. C. K., Chan, L. Y. Y., Guo, H., Lai, K. N. (2009). Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy. Nephrol Dial Transplant 24: 2067-2077 [Abstract] [Full Text]  
• Espinosa, M., Ortega, R., Gomez-Carrasco, J. M., Lopez-Rubio, F., Lopez-Andreu, M., Lopez-Oliva, M. O., Aljama, P. (2009). Mesangial C4d deposition: a new prognostic factor in IgA nephropathy. Nephrol Dial Transplant 24: 886-891 [Abstract] [Full Text]  
• Hassan, I. R., Gronert, K. (2009). Acute Changes in Dietary {omega}-3 and {omega}-6 Polyunsaturated Fatty Acids Have a Pronounced Impact on Survival following Ischemic Renal Injury and Formation of Renoprotective Docosahexaenoic Acid-Derived Protectin D1. J. Immunol. 182: 3223-3232 [Abstract] [Full Text]  
• Malycha, F., Eggermann, T., Hristov, M., Schena, F. P., Mertens, P. R., Zerres, K., Floege, J., Eitner, F. (2009). No evidence for a role of cosmc-chaperone mutations in European IgA nephropathy patients. Nephrol Dial Transplant 24: 321-324 [Abstract] [Full Text]  
• Mariotti, A. J., Agrawal, R., Hotaling, A. J. (2009). The Role of Tonsillectomy in Pediatric IgA Nephropathy. Arch Otolaryngol Head Neck Surg 135: 85-87 [Abstract] [Full Text]  
• Park, E.-K., Jeon, J.-S., Noh, H.-J., Won, J.-H., Park, H.-S. (2008). Complete remission of IgA nephropathy after bone marrow transplantation for acute myeloid leukaemia. NDT Plus 1: 420-422 [Abstract] [Full Text]  
• Yuling, H., Ruijing, X., Xiang, J., Yanping, J., Lang, C., Li, L., Dingping, Y., Xinti, T., Jingyi, L., Zhiqing, T., Yongyi, B., Bing, X., Xinxing, W., Youxin, J., Fox, D. A., Lundy, S. K., Guohua, D., Jinquan, T. (2008). CD19+CD5+ B Cells in Primary IgA Nephropathy. J. Am. Soc. Nephrol. 19: 2130-2139 [Abstract] [Full Text]  
• GLASSOCK, R. J. (2008). IgA nephropathy: Challenges and opportunities. Cleveland Clinic Journal of Medicine 75: 569-576 [Abstract] [Full Text]  
• Eitner, F., Floege, J. (2008). Bacterial protease for the treatment of IgA nephropathy. Nephrol Dial Transplant 23: 2173-2175 [Full Text]  
• Qin, W., Zhong, X., Fan, J. M., Zhang, Y. J., Liu, X. R., Ma, X. Y. (2008). External suppression causes the low expression of the Cosmc gene in IgA nephropathy. Nephrol Dial Transplant 23: 1608-1614 [Abstract] [Full Text]  
• Beli, E., Li, M., Cuff, C., Pestka, J. J. (2008). Docosahexaenoic Acid-Enriched Fish Oil Consumption Modulates Immunoglobulin Responses to and Clearance of Enteric Reovirus Infection in Mice. J. Nutr. 138: 813-819 [Abstract] [Full Text]  
• Eijgenraam, J.-W., Reinartz, S. M., Kamerling, S. W. A., van Ham, V. J., Zuidwijk, K., van Drunen, C. M., Daha, M. R., Fokkens, W. J., van Kooten, C. (2008). Immuno-histological analysis of dendritic cells in nasal biopsies of IgA nephropathy patients. Nephrol Dial Transplant 23: 612-620 [Abstract] [Full Text]  
• Giannakakis, K., Feriozzi, S., Perez, M., Faraggiana, T., Muda, A. O. (2007). Aberrantly Glycosylated IgA1 in Glomerular Immune Deposits of IgA Nephropathy. J. Am. Soc. Nephrol. 18: 3139-3146 [Full Text]  
• Oortwijn, B. D., Rastaldi, M. P., Roos, A., Mattinzoli, D., Daha, M. R., van Kooten, C. (2007). Demonstration of secretory IgA in kidneys of patients with IgA nephropathy. Nephrol Dial Transplant 22: 3191-3195 [Abstract] [Full Text]  
• Revert, F., Merino, R., Monteagudo, C., Macias, J., Peydro, A., Alcacer, J., Muniesa, P., Marquina, R., Blanco, M., Iglesias, M., Revert-Ros, F., Merino, J., Saus, J. (2007). Increased Goodpasture Antigen-Binding Protein Expression Induces Type IV Collagen Disorganization and Deposit of Immunoglobulin A in Glomerular Basement Membrane. Am. J. Pathol. 171: 1419-1430 [Abstract] [Full Text]  
• Won, Y.-W., Han, S.-W., Kim, H.-J., Oh, Y.-H., Park, M.-H. (2007). Spontaneous renal pelvic haematoma mimicking cancer in IgA nephropathy. Nephrol Dial Transplant 22: 254-256 [Full Text]  
• Gutierrez, E., Gonzalez, E., Hernandez, E., Morales, E., Martinez, M. A., Usera, G., Praga, M. (2007). Factors That Determine an Incomplete Recovery of Renal Function in Macrohematuria-Induced Acute Renal Failure of IgA Nephropathy. CJASN 2: 51-57 [Abstract] [Full Text]  
• Oortwijn, B. D., Roos, A., Royle, L., van Gijlswijk-Janssen, D. J., Faber-Krol, M. C., Eijgenraam, J.-W., Dwek, R. A., Daha, M. R., Rudd, P. M., van Kooten, C. (2006). Differential Glycosylation of Polymeric and Monomeric IgA: A Possible Role in Glomerular Inflammation in IgA Nephropathy. J. Am. Soc. Nephrol. 17: 3529-3539 [Abstract] [Full Text]  
• Matousovic, K., Novak, J., Yanagihara, T., Tomana, M., Moldoveanu, Z., Kulhavy, R., Julian, B. A., Konecny, K., Mestecky, J. (2006). IgA-containing immune complexes in the urine of IgA nephropathy patients. Nephrol Dial Transplant 21: 2478-2484 [Abstract] [Full Text]  
• Roos, A., Rastaldi, M. P., Calvaresi, N., Oortwijn, B. D., Schlagwein, N., van Gijlswijk-Janssen, D. J., Stahl, G. L., Matsushita, M., Fujita, T., van Kooten, C., Daha, M. R. (2006). Glomerular Activation of the Lectin Pathway of Complement in IgA Nephropathy Is Associated with More Severe Renal Disease. J. Am. Soc. Nephrol. 17: 1724-1734 [Abstract] [Full Text]  
• Yoshikawa, N., Honda, M., Iijima, K., Awazu, M., Hattori, S., Nakanishi, K., Ito, H., for the Japanese Pediatric IgA Nephropathy Treatme, (2006). Steroid Treatment for Severe Childhood IgA Nephropathy: A Randomized, Controlled Trial. CJASN 1: 511-517 [Abstract] [Full Text]  
• Tomita, M., Sogabe, H., Nakazato, S., Nakatsuji, S., Noto, T., Hamada, K., Kawachi, H., Shimizu, F., Matsuo, M., Mutoh, S. (2005). Monoclonal antibody 1-22-3-induced glomerulonephritis in uninephrectomized rats as a model of progressive renal failure. Nephrol Dial Transplant 20: 2358-2367 [Abstract] [Full Text]  
• Tuffin, G., Waelti, E., Huwyler, J., Hammer, C., Marti, H.-P. (2005). Immunoliposome Targeting to Mesangial Cells: A Promising Strategy for Specific Drug Delivery to the Kidney. J. Am. Soc. Nephrol. 16: 3295-3305 [Abstract] [Full Text]  
• Frisch, G., Lin, J., Rosenstock, J., Markowitz, G., D'Agati, V., Radhakrishnan, J., Preddie, D., Crew, J., Valeri, A., Appel, G. (2005). Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial. Nephrol Dial Transplant 20: 2139-2145 [Abstract] [Full Text]  
• Yamada, M., Katsuma, S., Adachi, T., Hirasawa, A., Shiojima, S., Kadowaki, T., Okuno, Y., Koshimizu, T.-a., Fujii, S., Sekiya, Y., Miyamoto, Y., Tamura, M., Yumura, W., Nihei, H., Kobayashi, M., Tsujimoto, G. (2005). Inhibition of protein kinase CK2 prevents the progression of glomerulonephritis. Proc. Natl. Acad. Sci. USA 102: 7736-7741 [Abstract] [Full Text]  
• Wu, J., Chen, X., Xie, Y., Yamanaka, N., Shi, S., Wu, D., Liu, S., Cai, G. (2005). Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy. Nephrol Dial Transplant 20: 719-727 [Abstract] [Full Text]  
• Myllymaki, J., Honkanen, T., Syrjanen, J., Helin, H., Rantala, I., Pasternack, A., Mustonen, J. (2005). Uric acid correlates with the severity of histopathological parameters in IgA nephropathy. Nephrol Dial Transplant 20: 89-95 [Abstract] [Full Text]  
• Steele, D. J.R., Michaels, P. J. (2004). Case 40-2004 - A 42-Year-Old Woman with Long-Standing Hematuria. NEJM 351: 2851-2859 [Full Text]  
• Jia, Q., Zhou, H.-R., Bennink, M., Pestka, J. J. (2004). Docosahexaenoic Acid Attenuates Mycotoxin-Induced Immunoglobulin A Nephropathy, Interleukin-6 Transcription, and Mitogen-Activated Protein Kinase Phosphorylation in Mice. J. Nutr. 134: 3343-3349 [Abstract] [Full Text]  
• Li, Y.-J., Du, Y., Li, C.-X., Guo, H., Leung, J. C.K., Lam, M. F., Yang, N., Huang, F., Chen, Y., Fang, J.-Q., Maxwell, P. H., Lai, K. N., Wang, Y. (2004). Family-Based Association Study Showing that Immunoglobulin A Nephropathy Is Associated with the Polymorphisms 2093C and 2180T in the 3' Untranslated Region of the Megsin Gene. J. Am. Soc. Nephrol. 15: 1739-1743 [Abstract] [Full Text]  
• Marquina, R., Diez, M. A., Lopez-Hoyos, M., Buelta, L., Kuroki, A., Kikuchi, S., Villegas, J., Pihlgren, M., Siegrist, C.-A., Arias, M., Izui, S., Merino, J., Merino, R. (2004). Inhibition of B Cell Death Causes the Development of an IgA Nephropathy in (New Zealand White x C57BL/6)F1-bcl-2 Transgenic Mice. J. Immunol. 172: 7177-7185 [Abstract] [Full Text]  
• Chen, X., Qiu, Q., Tang, L., Liu, S., Cai, G., Liu, H., Xie, Y. (2004). Effects of co-administration of urokinase and benazepril on severe IgA nephropathy. Nephrol Dial Transplant 19: 852-857 [Abstract] [Full Text]  
• Steinmetz, O. M., Panzer, U., Harendza, S., Mertens, P. R., Ostendorf, T., Floege, J., Helmchen, U., Stahl, R. A. K. (2004). No association of the -2518 MCP-1 A/G promoter polymorphism with incidence and clinical course of IgA nephropathy. Nephrol Dial Transplant 19: 596-601 [Abstract] [Full Text]  
• Batten, M., Fletcher, C., Ng, L. G., Groom, J., Wheway, J., Laabi, Y., Xin, X., Schneider, P., Tschopp, J., Mackay, C. R., Mackay, F. (2004). TNF Deficiency Fails to Protect BAFF Transgenic Mice against Autoimmunity and Reveals a Predisposition to B Cell Lymphoma. J. Immunol. 172: 812-822 [Abstract] [Full Text]  
• Kimmel, P. L., Barisoni, L., Kopp, J. B. (2003). Pathogenesis and Treatment of HIV-Associated Renal Diseases: Lessons from Clinical and Animal Studies, Molecular Pathologic Correlations, and Genetic Investigations. ANN INTERN MED 139: 214-226 [Abstract] [Full Text]  
• Ng, R. (2003). Fish Oil Therapy in Recurrent IgA Nephropathy. ANN INTERN MED 138: 1011-1011 [Full Text]  
• Praga, M., Gutierrez, E., Gonzalez, E., Morales, E., Hernandez, E. (2003). Treatment of IgA Nephropathy with ACE Inhibitors: A Randomized and Controlled Trial. J. Am. Soc. Nephrol. 14: 1578-1583 [Abstract] [Full Text]  
• Dean, H., Sellers, E., Birk, P., Blydt-Hansen, T., Ogborn, M. (2003). Children are not small adults. CMAJ 168: 255-256 [Full Text]  
• Heine, G., Sester, U., Kohler, H., Wardle, E. N., Sedlacek, M., Donadio, J. V., Grande, J. P. (2003). IgA Nephropathy. NEJM 348: 79-81 [Full Text]